Advanced Search

Submit Manuscript

ADVANCE ONLINE PUBLICATION  |  Open Access

ORIGINAL ARTICLES

Dietary cysteine drives body fat loss via FMRFamide signaling in Drosophila and mouse

Tingting Song1,† , Wusa Qin1,† , Zeliang Lai2,† , Haoyu Li2,† , Daihan Li2,† , Baojia Wang1 , Wuquan Deng3 , Tingzhang Wang1 , Liming Wang1,4,* , Rui Huang2,*

1Institute of Molecular Physiology, Shenzhen Bay Laboratory, Shenzhen, Guangdong, China
2Center for Neurointelligence, School of Medicine, Chongqing University, Chongqing, China
3Department of Endocrinology and Nephrology, Chongqing University Central Hospital, Chongqing Emergency Medical Center, Chongqing, China
4Department of General Surgery, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China
These authors contributed equally: Tingting Song, Wusa Qin, Zeliang Lai, Haoyu Li, Daihan Li
* Correspondence: Liming Wang(lmwang83@szbl.ac.cn)Rui Huang(huangrui85@cqu.edu.cn)

Obesity imposes a global health threat and calls for safe and effective therapeutic options. Here, we found that protein-rich diet significantly reduced body fat storage in fruit flies, which was largely attributed to dietary cysteine intake. Mechanistically, dietary cysteine increased the production of a neuropeptide FMRFamide (FMRFa). Enhanced FMRFa activity simultaneously promoted energy expenditure and suppressed food intake through its cognate receptor (FMRFaR), both contributing to the fat loss effect. In the fat body, FMRFa signaling promoted lipolysis by increasing PKA and lipase activity. In sweet-sensing gustatory neurons, FMRFa signaling suppressed appetitive perception and hence food intake. We also demonstrated that dietary cysteine worked in a similar way in mice via neuropeptide FF (NPFF) signaling, a mammalian RFamide peptide. In addition, dietary cysteine or FMRFa/NPFF administration provided protective effect against metabolic stress in flies and mice without behavioral abnormalities. Therefore, our study reveals a novel target for the development of safe and effective therapies against obesity and related metabolic diseases.

https://doi.org/10.1038/s41422-023-00800-8

FULL TEXT | PDF

Browse 228